Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions - Changes in Goodwill (Details)

v3.3.0.814
Composition of Certain Financial Statement Captions - Changes in Goodwill (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2015
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 224,292 [1]
Acquisitions and deconsolidation 538,021
Foreign exchange (1,079)
Ending balance 761,234
Pharmaceuticals | CURNA  
Goodwill [Roll Forward]  
Beginning balance 4,827
Acquisitions and deconsolidation 0
Foreign exchange 0
Ending balance 4,827
Pharmaceuticals | EirGen  
Goodwill [Roll Forward]  
Beginning balance 0
Acquisitions and deconsolidation 66,823
Foreign exchange 273
Ending balance 67,096
Pharmaceuticals | FineTech  
Goodwill [Roll Forward]  
Beginning balance 11,698
Acquisitions and deconsolidation 0
Foreign exchange 0
Ending balance 11,698
Pharmaceuticals | OPKO Renal  
Goodwill [Roll Forward]  
Beginning balance 5,283
Acquisitions and deconsolidation 0
Foreign exchange (739)
Ending balance 4,544
Pharmaceuticals | OPKO Biologics  
Goodwill [Roll Forward]  
Beginning balance 139,784
Acquisitions and deconsolidation 0
Foreign exchange 0
Ending balance 139,784
Pharmaceuticals | OPKO Health Europe  
Goodwill [Roll Forward]  
Beginning balance 8,013
Acquisitions and deconsolidation 0
Foreign exchange (600)
Ending balance 7,413
Pharmaceuticals | OPKO Mexico  
Goodwill [Roll Forward]  
Beginning balance 100
Acquisitions and deconsolidation 0
Foreign exchange (13)
Ending balance 87
Pharmaceuticals | OPKO Renal  
Goodwill [Roll Forward]  
Beginning balance 2,069
Acquisitions and deconsolidation 0
Foreign exchange 0
Ending balance 2,069
Pharmaceuticals | SciVac  
Goodwill [Roll Forward]  
Beginning balance 1,553
Acquisitions and deconsolidation (1,553)
Foreign exchange 0
Ending balance 0
Diagnostics | Bio-Reference  
Goodwill [Roll Forward]  
Beginning balance 0
Acquisitions and deconsolidation 472,751
Foreign exchange 0
Ending balance 472,751
Diagnostics | OPKO Diagnostics  
Goodwill [Roll Forward]  
Beginning balance 17,977
Acquisitions and deconsolidation 0
Foreign exchange 0
Ending balance 17,977
Diagnostics | OPKO Lab  
Goodwill [Roll Forward]  
Beginning balance 32,988
Acquisitions and deconsolidation 0
Foreign exchange 0
Ending balance $ 32,988
[1] As of December 31, 2014, total assets include $7.6 million and total liabilities include $12.1 million related to SciVac Ltd (“SciVac”). SciVac was a consolidated variable interest entity which we deconsolidated in July 2015. Refer to Note 5. SciVac’s consolidated assets were owned by SciVac and SciVac’s consolidated liabilities had no recourse against us.